Appointments at Catalent, Norwich Pharmaceuticals and Prism Ideas – People on the move

By Nick Taylor

- Last updated on GMT

Related tags: Catalent pharma solutions, Medicine

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Norwich Pharmaceuticals and Prism Ideas.

Catalent Pharma Solutions​ has made three appointments to strengthen its pharma manufacturing network. Jochen Roche​, a former BASF employee, has been named country general manager, softgel manufacturing at Catalent Japan.

David Bricker​ has been appointed general manager, sterile technologies at Catalent’s Woodstock blow, fill and seal facility. Bricker has previously worked at Boehringer Ingelheim and AstraZeneca.

Finally, Sergio Alter​, a former employee of Sandoz and Janssen-Cilag, has been appointed as general manager at Catalent Buenos Aires. Catalent recently expanded its Buenos Aires softgel manufacturing facility.

Prism Ideas​ has named Carol Hills​ as chief operations officer. Hills has more than 20 years of pharma experience at companies including Glaxo Group Research and AstraZeneca.

Terence Novak​ has joined Norwich Pharmaceuticals​ as president, commercial operations. Novak has previously worked at Bristol-Myers Squibb, DSM Pharmaceuticals and Patheon.

RSSL Pharma​ has hired Louis McMahon​ as pharmaceutical consultant. McMahon has 13 years of pharma manufacturing experience working at Novartis, Biovail, Wyeth and Pfizer.

Louis Weiner​ has been appointed vice president (VP) of sales and LLC member at A+ Secure Packaging​. Weiner has previously worked at Catalent Pharma Solutions in his 27 years in the contract pharmaceutical packaging industry.

TGaSAdvisors​ has added three senior level employees. Anna McClafferty​ has been named VP, management advisor, oversees marketing sciences, global marketing and executive commercial operations practices.

Also, Joe Falcon​ has joined as VP, management advisor, for the managed markets practice. Finally, Thomas “TJ” Scott​ has been appointed as director, management advisor, for the marketing sciences solution.

Synarc​ has strengthened its cardiac imaging trial services business by appointing Peter Milner​, co-founder of CV Therapeutics, ARYx Therapeutics and Optivia Biotechnology.

Related topics: Markets & Regulations

Related news

Show more

Follow us

Products

View more

Webinars